Partners

Being ready for changes in healthcare delivery and personalized medicine will help improve competitiveness in a market where large reference laboratories are vying for patient samples, hospitals are consolidating physician practices, diagnostic centers, and other outsourced services, and diagnostic manufacturers are offering laboratory services for their own commercial products. Clinically, MPLN can help develop your laboratory operation to bring on new tests and technologies. With more than three decades of experience, MPLN can offer our vast resources and knowledge toward getting started in flow cytometry or molecular diagnostics; we provide consultation and laboratory management options and work with your existing infrastructure and personnel or provide total laboratory operation.

Within the biopharma sector, MPLN can assist medical device and drug discovery companies in expanding their product portfolio by supporting on-study, phase 1-4 clinical trial testing. MPLN specializes in molecular and cellular testing, the validation of new biomarkers, and companion diagnostics. By working within a GCLP and CLIA environment, MPLN delivers high-quality operations, data integrity, and expert protocol collaboration. We provide personalized services for studies with few patients to those involving thousands of specimens collected globally.

Our Partners Program offers clinical laboratory, clinical research, and business expertise in molecular pathology. MPLN is a private company that can integrate with your clinical and research development teams. We employ the latest molecular and cellular technologies to support and integrate anatomic pathology data, providing timely actionable data to help you make faster, better-informed decisions.